Trials that use: Covariate adjustment
5,848 results
- SUN1058Independent statistical analysis of A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone: primary endpoint results, effect estimate with confidence interval,…
- Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC): Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sunshine 2 Study for Women With Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Sunshine 2 Study for Women With Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01904032).
- Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux: Complete Statistical AnalysisIndependent statistical analysis of Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01499953).
- SUPERNOVAIndependent statistical analysis of the randomized phase 2/3 SUPERNOVA trial of AZD3152 and AZD7442 for prevention of COVID-19, including non-inferiority, superiority, Poisson regression, ANOVA, safety, and interpretation of reported results.
- SuperShelfIndependent statistical analysis of A Multilevel Intervention in the Hunger Relief Network to Improve Diet Among Adults Experiencing Food Insecurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Supplementation With Cholecalciferol in Dialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of Supplementation With Cholecalciferol in Dialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01974245).
- SUPPORTIndependent statistical analysis of A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Supported Employment in Patient Aligned Care Teams: Complete Statistical AnalysisIndependent statistical analysis of Supported Employment in Patient Aligned Care Teams: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02400736).
- Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01352416).
- Suppression of HIV 1 RNA in People Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Suppression of HIV 1 RNA in People Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02363387).
- SUPREMEIndependent statistical analysis of Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.: Complete Statistical AnalysisIndependent statistical analysis of SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Surgeon Infiltration QL Block Comparison: Complete Statistical AnalysisIndependent statistical analysis of Surgeon Infiltration QL Block Comparison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03496610).
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix: Complete Statistical AnalysisIndependent statistical analysis of Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen: Complete Statistical AnalysisIndependent statistical analysis of Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand: Complete Statistical AnalysisIndependent statistical analysis of Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SURMOUNT-CNIndependent statistical analysis of A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SURMOUNT-OSAIndependent statistical analysis of SURMOUNT-OSA, a randomized phase 3 trial of tirzepatide in participants with obstructive sleep apnea and obesity, including AHI results, ANCOVA, logistic regression, confidence intervals, and safety.
- SURPASSIndependent statistical analysis of Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SURPASS-6Independent statistical analysis of A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin: primary endpoint results,…
- SURPHIndependent statistical analysis of A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine: Complete Statistical AnalysisIndependent statistical analysis of Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SUSTAINIndependent statistical analysis of Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT): primary endpoint results, effect estimate…
- SUSTAIN™ 2Complete statistical analysis of SUSTAIN™ 2, a randomized phase 3 trial comparing once-weekly semaglutide with once-daily sitagliptin as add-on therapy in subjects with type 2 diabetes.
- SUSTAIN™ 5Independent statistical analysis of Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes: primary…
- Suvorexant and Trauma Related Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Suvorexant and Trauma Related Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02704754).
- SWEDESIndependent statistical analysis of Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SweetDreams Sleep Study for Children With Autism: Complete Statistical AnalysisIndependent statistical analysis of SweetDreams Sleep Study for Children With Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04452045).
- SweetNalIndependent statistical analysis of Sweet Preference and Alcohol Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01296646).
- SWIFTIndependent statistical analysis of Safety and Efficacy Study of Switching From Epzicom to Truvada: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00724711).
- SWIFTIndependent statistical analysis of SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01054560).
- SWIFT-1Independent statistical analysis of Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SWITCHIndependent statistical analysis of Sleep Without Insomnia or The Use of Chronic Hypnotics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03687086).
- SWITCH 2Independent statistical analysis of A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate…
- SWITCH PROIndependent statistical analysis of A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study:…
- Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years: Complete Statistical AnalysisIndependent statistical analysis of Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years: primary endpoint…
- SYGMA2Complete statistical analysis of SYGMA2, a randomized phase 3 trial evaluating as-needed budesonide/formoterol versus twice-daily budesonide with as-needed terbutaline in adults and adolescents with asthma.
- Symplicity AFIndependent statistical analysis of Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Symptoms-StepsIndependent statistical analysis of In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis: Complete Statistical AnalysisIndependent statistical analysis of Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00361283).
- Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF: Complete Statistical AnalysisIndependent statistical analysis of Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02118831).
- T-jet®Independent statistical analysis of Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- T1GERIndependent statistical analysis of A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- T2D_MTUIndependent statistical analysis of Impact of Muscle and Tendon Dysfunction in People With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- T3PAHIndependent statistical analysis of Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03528902).
- Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: primary endpoint results,…